Search

Your search keyword '"H. Patterson"' showing total 2,608 results

Search Constraints

Start Over You searched for: Author "H. Patterson" Remove constraint Author: "H. Patterson"
2,608 results on '"H. Patterson"'

Search Results

1. 'I see my culture starting to disappear': Anishinaabe perspectives on the socioecological impacts of climate change and future research needs

2. Seeding roadsides is necessary but not sufficient for restoring native floral communities

3. Addressing inequities in the otolaryngology academic publishing: A call to action

4. 2-Benzoyl-4-phenyl-1,2,5-thiadiazol-3(2H)-one 1,1-Dioxide

5. Industry influence on mental health research: depression as a case example

6. Treatment-resistant depression reconsidered

7. Medical students’ knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer

8. Impact of out-of-pocket expenses for surgical care on households in rural Haiti: a mixed-methods study

9. Imaging of fluorescence anisotropy during photoswitching provides a simple readout for protein self-association

10. Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids

16. Superresolution Imaging Identifies That Conventional Trafficking Pathways Are Not Essential for Endoplasmic Reticulum to Outer Mitochondrial Membrane Protein Transport

17. Reporting of surgical response to disasters in low-income and middle-income countries: a literature review

21. Supplementary Figure 2 from Antitumor Activity of a Duocarmycin Analogue Rationalized to Be Metabolically Activated by Cytochrome P450 1A1 in Human Transitional Cell Carcinoma of the Bladder

22. Data from Antitumor Activity of a Duocarmycin Analogue Rationalized to Be Metabolically Activated by Cytochrome P450 1A1 in Human Transitional Cell Carcinoma of the Bladder

23. Supplementary Figure 1 from Antitumor Activity of a Duocarmycin Analogue Rationalized to Be Metabolically Activated by Cytochrome P450 1A1 in Human Transitional Cell Carcinoma of the Bladder

24. Supplementary Methods from Antitumor Activity of a Duocarmycin Analogue Rationalized to Be Metabolically Activated by Cytochrome P450 1A1 in Human Transitional Cell Carcinoma of the Bladder

25. Supplementary Table 2 from Antitumor Activity of a Duocarmycin Analogue Rationalized to Be Metabolically Activated by Cytochrome P450 1A1 in Human Transitional Cell Carcinoma of the Bladder

26. Supplementary Table 1 from Antitumor Activity of a Duocarmycin Analogue Rationalized to Be Metabolically Activated by Cytochrome P450 1A1 in Human Transitional Cell Carcinoma of the Bladder

27. Data from Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant Progression

30. Data from Colon Cancer–Specific Cytochrome P450 2W1 Converts Duocarmycin Analogues into Potent Tumor Cytotoxins

32. Data from Development of a Novel Tumor-Targeted Vascular Disrupting Agent Activated by Membrane-Type Matrix Metalloproteinases

33. Advances in continuous polymer analysis in flow with application towards biopolymers

34. Supplementary Data from Development of a Novel Tumor-Targeted Vascular Disrupting Agent Activated by Membrane-Type Matrix Metalloproteinases

37. Introduction

42. Front Cover

Catalog

Books, media, physical & digital resources